
| (Exact name of registrant as specified in its charter) | ||
| (State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
| (Address of principal executive offices and Zip Code) | ||
( | ||
| (Registrant’s telephone number, including area code) | ||
| Title of each class | Trading symbol | Name of each exchange on which registered | ||||||||||||
| Item 2.02. | Results of Operations and Financial Condition. | ||||
| Item 9.01. | Financial Statements and Exhibits. | ||||
| (d) Exhibits. | |||||
| Exhibit No. | Description | |||||||
| 99.1 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
| MICRON TECHNOLOGY, INC. | |||||||||||
| Date: | By: | /s/ Mark Murphy | |||||||||
| Name: | Mark Murphy | ||||||||||
| Title: | Executive Vice President and Chief Financial Officer | ||||||||||
| Contacts: | Satya Kumar | Mark Plungy | ||||||
| Investor Relations | Media Relations | |||||||
| [email protected] | ||||||||
(408) 450-6199 | (408) 203-2910 | |||||||
| Quarterly Financial Results | |||||||||||||||||||||||
| (in millions, except per share amounts) | GAAP(1) | Non-GAAP(2) | |||||||||||||||||||||
FQ2-25 | FQ1-25 | FQ2-24 | FQ2-25 | FQ1-25 | FQ2-24 | ||||||||||||||||||
| Revenue | $ | 8,053 | $ | 8,709 | $ | 5,824 | $ | 8,053 | $ | 8,709 | $ | 5,824 | |||||||||||
| Gross margin | 2,963 | 3,348 | 1,079 | 3,053 | 3,441 | 1,163 | |||||||||||||||||
| percent of revenue | 36.8 | % | 38.4 | % | 18.5 | % | 37.9 | % | 39.5 | % | 20.0 | % | |||||||||||
| Operating expenses | 1,190 | 1,174 | 888 | 1,046 | 1,047 | 959 | |||||||||||||||||
Operating income | 1,773 | 2,174 | 191 | 2,007 | 2,394 | 204 | |||||||||||||||||
| percent of revenue | 22.0 | % | 25.0 | % | 3.3 | % | 24.9 | % | 27.5 | % | 3.5 | % | |||||||||||
Net income | 1,583 | 1,870 | 793 | 1,783 | 2,037 | 476 | |||||||||||||||||
Diluted earnings per share | 1.41 | 1.67 | 0.71 | 1.56 | 1.79 | 0.42 | |||||||||||||||||
| FQ3-25 | GAAP(1) Outlook | Non-GAAP(2) Outlook | ||||||
Revenue | $8.80 billion ± $200 million | $8.80 billion ± $200 million | ||||||
Gross margin | 35.5% ± 1.0% | 36.5% ± 1.0% | ||||||
Operating expenses | $1.27 billion ± $15 million | $1.13 billion ± $15 million | ||||||
Diluted earnings per share | $1.37 ± $0.10 | $1.57 ± $0.10 | ||||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | Six months ended | ||||||||||||||
| February 27, 2025 | November 28, 2024 | February 29, 2024 | February 27, 2025 | February 29, 2024 | |||||||||||||
| Revenue | $ | 8,053 | $ | 8,709 | $ | 5,824 | $ | 16,762 | $ | 10,550 | |||||||
| Cost of goods sold | 5,090 | 5,361 | 4,745 | 10,451 | 9,506 | ||||||||||||
| Gross margin | 2,963 | 3,348 | 1,079 | 6,311 | 1,044 | ||||||||||||
| Research and development | 898 | 888 | 832 | 1,786 | 1,677 | ||||||||||||
| Selling, general, and administrative | 285 | 288 | 280 | 573 | 543 | ||||||||||||
| Other operating (income) expense, net | 7 | (2) | (224) | 5 | (239) | ||||||||||||
| Operating income (loss) | 1,773 | 2,174 | 191 | 3,947 | (937) | ||||||||||||
| Interest income | 108 | 107 | 130 | 215 | 262 | ||||||||||||
| Interest expense | (112) | (118) | (144) | (230) | (276) | ||||||||||||
| Other non-operating income (expense), net | (11) | (11) | (7) | (22) | (34) | ||||||||||||
| 1,758 | 2,152 | 170 | 3,910 | (985) | |||||||||||||
| Income tax (provision) benefit | (177) | (283) | 622 | (460) | 549 | ||||||||||||
| Equity in net income (loss) of equity method investees | 2 | 1 | 1 | 3 | (5) | ||||||||||||
| Net income (loss) | $ | 1,583 | $ | 1,870 | $ | 793 | $ | 3,453 | $ | (441) | |||||||
| Earnings (loss) per share | |||||||||||||||||
| Basic | $ | 1.42 | $ | 1.68 | $ | 0.72 | $ | 3.10 | $ | (0.40) | |||||||
| Diluted | 1.41 | 1.67 | 0.71 | 3.08 | (0.40) | ||||||||||||
| Number of shares used in per share calculations | |||||||||||||||||
| Basic | 1,115 | 1,111 | 1,104 | 1,113 | 1,102 | ||||||||||||
| Diluted | 1,123 | 1,122 | 1,114 | 1,123 | 1,102 | ||||||||||||
| As of | February 27, 2025 | November 28, 2024 | August 29, 2024 | ||||||||
| Assets | |||||||||||
| Cash and equivalents | $ | 7,552 | $ | 6,693 | $ | 7,041 | |||||
| Short-term investments | 663 | 895 | 1,065 | ||||||||
| Receivables | 6,504 | 7,423 | 6,615 | ||||||||
| Inventories | 9,007 | 8,705 | 8,875 | ||||||||
| Other current assets | 963 | 777 | 776 | ||||||||
| Total current assets | 24,689 | 24,493 | 24,372 | ||||||||
| Long-term marketable investments | 1,375 | 1,156 | 1,046 | ||||||||
| Property, plant, and equipment | 42,528 | 41,476 | 39,749 | ||||||||
| Operating lease right-of-use assets | 637 | 622 | 645 | ||||||||
| Intangible assets | 423 | 419 | 416 | ||||||||
| Deferred tax assets | 552 | 474 | 520 | ||||||||
| Goodwill | 1,150 | 1,150 | 1,150 | ||||||||
| Other noncurrent assets | 1,699 | 1,671 | 1,518 | ||||||||
| Total assets | $ | 73,053 | $ | 71,461 | $ | 69,416 | |||||
| Liabilities and equity | |||||||||||
| Accounts payable and accrued expenses | $ | 6,176 | $ | 7,126 | $ | 7,299 | |||||
| Current debt | 504 | 533 | 431 | ||||||||
| Other current liabilities | 1,197 | 1,356 | 1,518 | ||||||||
| Total current liabilities | 7,877 | 9,015 | 9,248 | ||||||||
| Long-term debt | 13,851 | 13,252 | 12,966 | ||||||||
| Noncurrent operating lease liabilities | 599 | 588 | 610 | ||||||||
| Noncurrent unearned government incentives | 836 | 570 | 550 | ||||||||
| Other noncurrent liabilities | 1,257 | 1,239 | 911 | ||||||||
| Total liabilities | 24,420 | 24,664 | 24,285 | ||||||||
| Commitments and contingencies | |||||||||||
| Shareholders’ equity | |||||||||||
| Common stock | 126 | 126 | 125 | ||||||||
| Additional capital | 12,711 | 12,317 | 12,115 | ||||||||
| Retained earnings | 43,839 | 42,427 | 40,877 | ||||||||
| Treasury stock | (7,852) | (7,852) | (7,852) | ||||||||
| Accumulated other comprehensive income (loss) | (191) | (221) | (134) | ||||||||
| Total equity | 48,633 | 46,797 | 45,131 | ||||||||
| Total liabilities and equity | $ | 73,053 | $ | 71,461 | $ | 69,416 | |||||
| Six months ended | February 27, 2025 | February 29, 2024 | ||||||
| Cash flows from operating activities | ||||||||
| Net income (loss) | $ | 3,453 | $ | (441) | ||||
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||||||||
| Depreciation expense and amortization of intangible assets | 4,109 | 3,839 | ||||||
Stock-based compensation | 469 | 401 | ||||||
Change in operating assets and liabilities: | ||||||||
| Receivables | 338 | (1,759) | ||||||
| Inventories | (132) | (57) | ||||||
Other current assets | (204) | (799) | ||||||
| Accounts payable and accrued expenses | (714) | 573 | ||||||
Other current liabilities | (321) | 706 | ||||||
| Other | 188 | 157 | ||||||
| Net cash provided by operating activities | 7,186 | 2,620 | ||||||
| Cash flows from investing activities | ||||||||
| Expenditures for property, plant, and equipment | (7,261) | (3,180) | ||||||
| Purchases of available-for-sale securities | (816) | (465) | ||||||
| Proceeds from government incentives | 1,028 | 234 | ||||||
Proceeds from maturities and sales of available-for-sale securities | 874 | 726 | ||||||
| Other | (125) | (24) | ||||||
| Net cash provided by (used for) investing activities | (6,300) | (2,709) | ||||||
| Cash flows from financing activities | ||||||||
| Repayments of debt | (2,626) | (1,101) | ||||||
| Payments of dividends to shareholders | (261) | (256) | ||||||
| Payments on equipment purchase contracts | — | (82) | ||||||
Proceeds from issuance of debt | 2,682 | 999 | ||||||
| Other | (121) | (18) | ||||||
| Net cash provided by (used for) financing activities | (326) | (458) | ||||||
Effect of changes in currency exchange rates on cash, cash equivalents, and restricted cash | (49) | (8) | ||||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | 511 | (555) | ||||||
| Cash, cash equivalents, and restricted cash at beginning of period | 7,052 | 8,656 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 7,563 | $ | 8,101 | ||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| February 27, 2025 | November 28, 2024 | February 29, 2024 | |||||||||
| GAAP gross margin | $ | 2,963 | $ | 3,348 | $ | 1,079 | |||||
| Stock-based compensation | 89 | 90 | 80 | ||||||||
| Other | 1 | 3 | 4 | ||||||||
| Non-GAAP gross margin | $ | 3,053 | $ | 3,441 | $ | 1,163 | |||||
| GAAP operating expenses | $ | 1,190 | $ | 1,174 | $ | 888 | |||||
| Stock-based compensation | (144) | (127) | (129) | ||||||||
| Patent cross-license agreement gain | — | — | 200 | ||||||||
| Non-GAAP operating expenses | $ | 1,046 | $ | 1,047 | $ | 959 | |||||
GAAP operating income | $ | 1,773 | $ | 2,174 | $ | 191 | |||||
| Stock-based compensation | 233 | 217 | 209 | ||||||||
| Patent cross-license agreement gain | — | — | (200) | ||||||||
| Other | 1 | 3 | 4 | ||||||||
Non-GAAP operating income | $ | 2,007 | $ | 2,394 | $ | 204 | |||||
GAAP net income | $ | 1,583 | $ | 1,870 | $ | 793 | |||||
| Stock-based compensation | 233 | 217 | 209 | ||||||||
| Patent cross-license agreement gain | — | — | (200) | ||||||||
| Other | 4 | — | 2 | ||||||||
Estimated tax effects of above and other tax adjustments | (37) | (50) | (328) | ||||||||
Non-GAAP net income | $ | 1,783 | $ | 2,037 | $ | 476 | |||||
GAAP weighted-average common shares outstanding - Diluted | 1,123 | 1,122 | 1,114 | ||||||||
Adjustment for stock-based compensation | 20 | 16 | 20 | ||||||||
Non-GAAP weighted-average common shares outstanding - Diluted | 1,143 | 1,138 | 1,134 | ||||||||
GAAP diluted earnings per share | $ | 1.41 | $ | 1.67 | $ | 0.71 | |||||
Effects of the above adjustments | 0.15 | 0.12 | (0.29) | ||||||||
Non-GAAP diluted earnings per share | $ | 1.56 | $ | 1.79 | $ | 0.42 | |||||
| 2nd Qtr. | 1st Qtr. | 2nd Qtr. | |||||||||
| February 27, 2025 | November 28, 2024 | February 29, 2024 | |||||||||
GAAP net cash provided by operating activities | $ | 3,942 | $ | 3,244 | $ | 1,219 | |||||
Expenditures for property, plant, and equipment | (4,055) | (3,206) | (1,384) | ||||||||
| Payments on equipment purchase contracts | — | — | (26) | ||||||||
| Proceeds from sales of property, plant, and equipment | 7 | 9 | 13 | ||||||||
Proceeds from government incentives | 963 | 65 | 149 | ||||||||
| Investments in capital expenditures, net | (3,085) | (3,132) | (1,248) | ||||||||
Adjusted free cash flow | $ | 857 | $ | 112 | $ | (29) | |||||
FQ3-25 | GAAP Outlook | Adjustments | Non-GAAP Outlook | ||||||||||||||||||||
Revenue | $8.80 billion ± $200 million | — | $8.80 billion ± $200 million | ||||||||||||||||||||
Gross margin | 35.5% ± 1.0% | 1.0% | A | 36.5% ± 1.0% | |||||||||||||||||||
Operating expenses | $1.27 billion ± $15 million | $144 million | B | $1.13 billion ± $15 million | |||||||||||||||||||
Diluted earnings per share(1) | $1.37 ± $0.10 | $0.20 | A, B, C | $1.57 ± $0.10 | |||||||||||||||||||
Non-GAAP Adjustments (in millions) | |||||||||||||||||||||||
A | Stock-based compensation – cost of goods sold | $ | 106 | ||||||||||||||||||||
B | Stock-based compensation – research and development | 89 | |||||||||||||||||||||
B | Stock-based compensation – sales, general, and administrative | 55 | |||||||||||||||||||||
C | Tax effects of the above items and other tax adjustments | (29) | |||||||||||||||||||||
| $ | 221 | ||||||||||||||||||||||